Copyright 2024
Medical Security Card Company, LLC
All Rights Reserved
WellRx will never sell your personal information. Period. By signing up I agree to WellRx's terms of use and privacy policy.
CAPMATINIB (kap MA ti nib) treats lung cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Capmatinib 150mg, Oral tablet
Caffeine-containing Foods/Beverages
· Severity: Moderate
· Notes for Consumers: Although an interaction is possible, these drugs can be used together. Side effects from Caffeine may get worse if you take these drugs together. Too much Caffeine can cause effects like nausea, nervousness, or sleeplessness. You may need to limit your Caffeine intake. Common foods and beverages containing caffeine include coffee, teas, colas and chocolate. Many non-prescription drugs and diet aids may also contain caffeine.
· Notes for Professionals: Reduction or limitation of the caffeine dosage in medications or caffeine in beverages and food may be necessary during concurrent capmatinib therapy. Monitor for an increase in caffeine-related adverse reactions if coadministration with capmatinib is necessary. Caffeine is a sensitive CYP1A2 substrate and capmatinib is a weak CYP1A2 inhibitor. Coadministration with capmatinib increased caffeine exposure by 134%.
Capmatinib 150mg, Oral tablet
Grapefruit juice
· Severity: Major
· Notes for Consumers: Do not eat grapefruit or drink grapefruit juice while taking Capmatinib. Side effects from Capmatinib may get worse if you take these drugs together. Contact your health care provider if you experience breathing problems, cough, nausea, vomiting, swelling of the ankles, feet, or hands, or other new or unusual side effects.
· Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice due to increased capatinib exposure resulting in treatment-related adverse events. Capatinib is a CYP3A4 substrate; grapefruit is a strong CYP3A4 inhibitor. Coadministration with another strong CYP3A4 inhibitor increased capmatinib exposure by 42%.
You need to log into the site to use this feature
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Manufacturer Coupons and Offers Available
Number of Uses:
tabrecta
150 MG | Tablet | 56 tablets
You need to log into the site to use this feature
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
You will be redirected to your program in 5 seconds.
Our Terms and Conditions and Privacy Policy have recently been updated.
By declining you will be logged out of your account